BENGALURU : Dr. Reddy's Laboratories and Global Response Aid FZCO said they terminated their clinical trial in Kuwait of Fujifilm Holdings' Covid-19 treatment Avigan in patients with moderate to severe symptoms.A late-stage North American trial of Avigan in patients with mild to moderate Covid-19 will continue, the Indian drugmaker said on Wednesday in a regulatory filing.Dr.
Reddy's said the data from the clinical trial in Kuwait involving moderate-severe Covid-19 hospitalized patients did not show a statistically significant difference for the primary endpoint.
The full data analysis on 353 subjects would be available by the end of February 2021. Click here to read the Mint ePaperMint is now on Telegram.